Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

The impact of strain-specific immunity on Lyme disease incidence is spatially heterogeneous.

Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Wormser GP, Brisson D.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):288-293. doi: 10.1016/j.diagmicrobio.2017.08.015. Epub 2017 Aug 25.

2.

Public health impact of strain specific immunity to Borrelia burgdorferi.

Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Levy MZ, Brisson D, Wormser GP.

BMC Infect Dis. 2015 Oct 26;15:472. doi: 10.1186/s12879-015-1190-7.

3.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

4.

Erythema migrans.

Nadelman RB.

Infect Dis Clin North Am. 2015 Jun;29(2):211-39. doi: 10.1016/j.idc.2015.02.001. Review.

PMID:
25999220
5.

Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Molla I, Dornbush R, Visintainer P, Nowakowski J.

Clin Infect Dis. 2015 Jul 15;61(2):244-7. doi: 10.1093/cid/civ277. Epub 2015 Apr 17.

PMID:
25888674
6.

Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S, Prakash P, Ash J, Nowakowski J.

Arthritis Rheumatol. 2015 Mar;67(3):837-839. doi: 10.1002/art.38972. Epub 2014 Dec 2.

7.

Long-term assessment of fatigue in patients with culture-confirmed Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Nowakowski J.

Am J Med. 2015 Feb;128(2):181-4. doi: 10.1016/j.amjmed.2014.09.022. Epub 2014 Oct 15.

PMID:
25447620
8.

Evidence for strain-specific immunity in patients treated for early lyme disease.

Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Wormser GP, Brisson D.

Infect Immun. 2014 Apr;82(4):1408-13. doi: 10.1128/IAI.01451-13. Epub 2014 Jan 13.

9.

Reinfection versus relapse in Lyme disease.

Nadelman RB, Wormser GP.

N Engl J Med. 2013 Mar 14;368(11):1063-4. doi: 10.1056/NEJMc1215615. No abstract available.

PMID:
23484837
10.

Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, Liveris D, Schwartz I, Horowitz HW.

J Clin Microbiol. 2013 Mar;51(3):954-8. doi: 10.1128/JCM.02929-12. Epub 2013 Jan 9.

11.

Differentiation of reinfection from relapse in recurrent Lyme disease.

Nadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, Brisson D, Cooper D, Bittker S, Madison G, Holmgren D, Schwartz I, Wormser GP.

N Engl J Med. 2012 Nov 15;367(20):1883-90. doi: 10.1056/NEJMoa1114362.

12.

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS.

Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11.

13.

The amber theory of Lyme arthritis: initial description and clinical implications.

Wormser GP, Nadelman RB, Schwartz I.

Clin Rheumatol. 2012 Jun;31(6):989-94. doi: 10.1007/s10067-012-1964-x. Epub 2012 Mar 13.

PMID:
22411576
14.

Antiscience and ethical concerns associated with advocacy of Lyme disease.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.

Lancet Infect Dis. 2011 Sep;11(9):713-9. doi: 10.1016/S1473-3099(11)70034-2.

15.

Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans.

Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman RB, DeMarco J, Iyer R, Cox ME, Holmgren D, Wormser GP.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):791-5. doi: 10.1007/s10096-011-1376-x. Epub 2011 Aug 16.

PMID:
21842448
16.

Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii.

Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, Ogrinc K, Stupica D, Nadelman RB, Nowakowski J, Wormser GP.

Vector Borne Zoonotic Dis. 2011 Sep;11(9):1253-8. doi: 10.1089/vbz.2010.0230. Epub 2011 May 25.

PMID:
21612533
17.

Babesiosis in Lower Hudson Valley, New York, USA.

Joseph JT, Roy SS, Shams N, Visintainer P, Nadelman RB, Hosur S, Nelson J, Wormser GP.

Emerg Infect Dis. 2011 May;17(5):843-7. doi: 10.3201/eid1705.101334.

18.

Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Sood SK, Weinstein A, Wormser GP.

J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21.

PMID:
21097940
19.

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis.

Warshafsky S, Lee DH, Francois LK, Nowakowski J, Nadelman RB, Wormser GP.

J Antimicrob Chemother. 2010 Jun;65(6):1137-44. doi: 10.1093/jac/dkq097. Epub 2010 Apr 9.

PMID:
20382722
20.

Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States.

Nowakowski J, McKenna D, Nadelman RB, Bittker S, Cooper D, Pavia C, Holmgren D, Visintainer P, Wormser GP.

Clin Infect Dis. 2009 Dec 1;49(11):1733-5. doi: 10.1086/648076.

PMID:
19886794

Supplemental Content

Loading ...
Support Center